<!DOCTYPE html>
<html lang="en-us">
  <head><script src="/livereload.js?mindelay=10&amp;v=2&amp;port=1313&amp;path=livereload" data-no-instant defer></script>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1">
    
    <title>Vitamin_E | Health for you life</title>
    <meta name="viewport" content="width=device-width,minimum-scale=1">
    <meta name="description" content="Vitamin E: Clinical Significance, Therapeutic Potential, and Associated Adverse Manifestations

1. Introduction
Vitamin E refers to a family of eight fat‑soluble compounds (α-, β-, γ-, δ-tocopherols and tocotrienols) that share a chromanol ring and a hydrophobic side chain. Among them, α‑tocopherol is the most biologically active form in humans, largely due to its preferential retention by hepatic α‑Tocopherol Transfer Protein (α‑TTP). The antioxidant, anti‑inflammatory, and membrane‑stabilizing properties of vitamin E have prompted extensive research into its role in chronic disease prevention and treatment. This review synthesizes current evidence on the clinical benefits of vitamin E, delineates the mechanisms underlying these effects, and discusses documented adverse events associated with both deficiency and supraphysiologic supplementation.">
    <meta name="generator" content="Hugo 0.148.2">
    
    
    
      <meta name="robots" content="noindex, nofollow">
    
    

    
<link rel="stylesheet" href="/ananke/css/main.min.css" >




    


    
      

    

    

    
      <link rel="canonical" href="http://localhost:1313/post/Vitamin_E.html">
    

    <meta property="og:url" content="http://localhost:1313/post/Vitamin_E.html">
  <meta property="og:site_name" content="Health for you life">
  <meta property="og:title" content="Vitamin_E">
  <meta property="og:description" content="Vitamin E: Clinical Significance, Therapeutic Potential, and Associated Adverse Manifestations
1. Introduction Vitamin E refers to a family of eight fat‑soluble compounds (α-, β-, γ-, δ-tocopherols and tocotrienols) that share a chromanol ring and a hydrophobic side chain. Among them, α‑tocopherol is the most biologically active form in humans, largely due to its preferential retention by hepatic α‑Tocopherol Transfer Protein (α‑TTP). The antioxidant, anti‑inflammatory, and membrane‑stabilizing properties of vitamin E have prompted extensive research into its role in chronic disease prevention and treatment. This review synthesizes current evidence on the clinical benefits of vitamin E, delineates the mechanisms underlying these effects, and discusses documented adverse events associated with both deficiency and supraphysiologic supplementation.">
  <meta property="og:locale" content="en_us">
  <meta property="og:type" content="article">
    <meta property="article:section" content="posts">
    <meta property="article:published_time" content="2025-08-20T00:00:00+00:00">
    <meta property="article:modified_time" content="2025-08-20T00:00:00+00:00">
    <meta property="article:tag" content="Vitamin">

  <meta itemprop="name" content="Vitamin_E">
  <meta itemprop="description" content="Vitamin E: Clinical Significance, Therapeutic Potential, and Associated Adverse Manifestations
1. Introduction Vitamin E refers to a family of eight fat‑soluble compounds (α-, β-, γ-, δ-tocopherols and tocotrienols) that share a chromanol ring and a hydrophobic side chain. Among them, α‑tocopherol is the most biologically active form in humans, largely due to its preferential retention by hepatic α‑Tocopherol Transfer Protein (α‑TTP). The antioxidant, anti‑inflammatory, and membrane‑stabilizing properties of vitamin E have prompted extensive research into its role in chronic disease prevention and treatment. This review synthesizes current evidence on the clinical benefits of vitamin E, delineates the mechanisms underlying these effects, and discusses documented adverse events associated with both deficiency and supraphysiologic supplementation.">
  <meta itemprop="datePublished" content="2025-08-20T00:00:00+00:00">
  <meta itemprop="dateModified" content="2025-08-20T00:00:00+00:00">
  <meta itemprop="wordCount" content="1034">
  <meta itemprop="keywords" content="Vitamin">
  <meta name="twitter:card" content="summary">
  <meta name="twitter:title" content="Vitamin_E">
  <meta name="twitter:description" content="Vitamin E: Clinical Significance, Therapeutic Potential, and Associated Adverse Manifestations
1. Introduction Vitamin E refers to a family of eight fat‑soluble compounds (α-, β-, γ-, δ-tocopherols and tocotrienols) that share a chromanol ring and a hydrophobic side chain. Among them, α‑tocopherol is the most biologically active form in humans, largely due to its preferential retention by hepatic α‑Tocopherol Transfer Protein (α‑TTP). The antioxidant, anti‑inflammatory, and membrane‑stabilizing properties of vitamin E have prompted extensive research into its role in chronic disease prevention and treatment. This review synthesizes current evidence on the clinical benefits of vitamin E, delineates the mechanisms underlying these effects, and discusses documented adverse events associated with both deficiency and supraphysiologic supplementation.">

	
  </head><body class="ma0 avenir bg-near-white development">

    
   
  

  <header>
    <div class="bg-black">
      <nav class="pv3 ph3 ph4-ns" role="navigation">
  <div class="flex-l center items-center justify-between">
    <a href="/" class="f3 fw2 hover-white white-90 dib no-underline">
      
        Health for you life
      
    </a>
    <div class="flex-l items-center">
      

      
        <ul class="pl0 mr3">
          
          <li class="list f5 f4-ns fw4 dib pr3">
            <a class="hover-white white-90 no-underline" href="/" title="Home page">
              Home
            </a>
          </li>
          
          <li class="list f5 f4-ns fw4 dib pr3">
            <a class="hover-white white-90 no-underline" href="/about/" title="About page">
              About
            </a>
          </li>
          
          <li class="list f5 f4-ns fw4 dib pr3">
            <a class="hover-white white-90 no-underline" href="/posts/" title="Posts page">
              Posts
            </a>
          </li>
          
        </ul>
      
      <div class="ananke-socials"></div>

    </div>
  </div>
</nav>

    </div>
  </header>



    <main class="pb7" role="main">
      
  
  
  <article class="flex-l mw8 center ph3 flex-wrap justify-between">
    <header class="mt4 w-100">
      <aside class="instapaper_ignoref b helvetica tracked ttu">
          
        Posts
      </aside><div id="sharing" class="mt3 ananke-socials"><a href="mailto:?&amp;body=http%3A%2F%2Flocalhost%3A1313%2Fpost%2FVitamin_E.html&amp;subject=Vitamin_E"
        class="ananke-social-link email no-underline"
        title="Share on Email" aria-label="Share on Email"
        target="_blank" rel="nofollow noopener noreferrer">
        <span class="icon">
                <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Free 6.6.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2024 Fonticons, Inc. --><path d="M64 112c-8.8 0-16 7.2-16 16l0 22.1L220.5 291.7c20.7 17 50.4 17 71.1 0L464 150.1l0-22.1c0-8.8-7.2-16-16-16L64 112zM48 212.2L48 384c0 8.8 7.2 16 16 16l384 0c8.8 0 16-7.2 16-16l0-171.8L322 328.8c-38.4 31.5-93.7 31.5-132 0L48 212.2zM0 128C0 92.7 28.7 64 64 64l384 0c35.3 0 64 28.7 64 64l0 256c0 35.3-28.7 64-64 64L64 448c-35.3 0-64-28.7-64-64L0 128z"/></svg>
                
              </span></a><a href="https://twitter.com/intent/tweet/?&amp;text=Vitamin%E2%80%AFE%3A&#43;Clinical&#43;Significance%2C&#43;Therapeutic&#43;Potential%2C&#43;and&#43;Associated&#43;Adverse&#43;Manifestations%0A1.&#43;Introduction&#43;Vitamin%E2%80%AFE&#43;refers&#43;to&#43;a&#43;family&#43;of&#43;eight&#43;fat%E2%80%91soluble&#43;compounds&#43;%28%CE%B1-%2C&#43;%CE%B2-%2C&#43;%CE%B3-%2C&#43;%CE%B4-tocopherols&#43;and&#43;tocotrienols%29&#43;that&#43;share&#43;a&#43;chromanol&#43;ring&#43;and&#43;a&#43;hydrophobic&#43;side&#43;chain.&#43;Among&#43;them%2C&#43;%CE%B1%E2%80%91tocopherol&#43;is&#43;the&#43;most&#43;biologically&#43;active&#43;form&#43;in&#43;humans%2C&#43;largely&#43;due&#43;to&#43;its&#43;preferential&#43;retention&#43;by&#43;hepatic&#43;%CE%B1%E2%80%91Tocopherol&#43;Transfer&#43;Protein&#43;%28%CE%B1%E2%80%91TTP%29.&#43;The&#43;antioxidant%2C&#43;anti%E2%80%91inflammatory%2C&#43;and&#43;membrane%E2%80%91stabilizing&#43;properties&#43;of&#43;vitamin%E2%80%AFE&#43;have&#43;prompted&#43;extensive&#43;research&#43;into&#43;its&#43;role&#43;in&#43;chronic&#43;disease&#43;prevention&#43;and&#43;treatment.&#43;This&#43;review&#43;synthesizes&#43;current&#43;evidence&#43;on&#43;the&#43;clinical&#43;benefits&#43;of&#43;vitamin%E2%80%AFE%2C&#43;delineates&#43;the&#43;mechanisms&#43;underlying&#43;these&#43;effects%2C&#43;and&#43;discusses&#43;documented&#43;adverse&#43;events&#43;associated&#43;with&#43;both&#43;deficiency&#43;and&#43;supraphysiologic&#43;supplementation.%0A&amp;url=http%3A%2F%2Flocalhost%3A1313%2Fpost%2FVitamin_E.html"
        class="ananke-social-link twitter no-underline"
        title="Share on Twitter" aria-label="Share on Twitter"
        target="_blank" rel="nofollow noopener noreferrer">
        <span class="icon">
                <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Free 6.6.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2024 Fonticons, Inc. --><path d="M459.37 151.716c.325 4.548.325 9.097.325 13.645 0 138.72-105.583 298.558-298.558 298.558-59.452 0-114.68-17.219-161.137-47.106 8.447.974 16.568 1.299 25.34 1.299 49.055 0 94.213-16.568 130.274-44.832-46.132-.975-84.792-31.188-98.112-72.772 6.498.974 12.995 1.624 19.818 1.624 9.421 0 18.843-1.3 27.614-3.573-48.081-9.747-84.143-51.98-84.143-102.985v-1.299c13.969 7.797 30.214 12.67 47.431 13.319-28.264-18.843-46.781-51.005-46.781-87.391 0-19.492 5.197-37.36 14.294-52.954 51.655 63.675 129.3 105.258 216.365 109.807-1.624-7.797-2.599-15.918-2.599-24.04 0-57.828 46.782-104.934 104.934-104.934 30.213 0 57.502 12.67 76.67 33.137 23.715-4.548 46.456-13.32 66.599-25.34-7.798 24.366-24.366 44.833-46.132 57.827 21.117-2.273 41.584-8.122 60.426-16.243-14.292 20.791-32.161 39.308-52.628 54.253z"/></svg>
                
              </span></a></div>
<h1 class="f1 athelas mt3 mb1">Vitamin_E</h1>
      
      
      
      <time class="f6 mv4 dib tracked" datetime="2025-08-20T00:00:00Z">August 20, 2025</time>
      

      
      
    </header>
    <div class="nested-copy-line-height lh-copy serif f4 nested-links mid-gray pr4-l w-two-thirds-l"><p><strong>Vitamin E: Clinical Significance, Therapeutic Potential, and Associated Adverse Manifestations</strong></p>
<hr>
<h3 id="1-introduction">1. Introduction</h3>
<p>Vitamin E refers to a family of eight fat‑soluble compounds (α-, β-, γ-, δ-tocopherols and tocotrienols) that share a chromanol ring and a hydrophobic side chain. Among them, α‑tocopherol is the most biologically active form in humans, largely due to its preferential retention by hepatic α‑Tocopherol Transfer Protein (α‑TTP). The antioxidant, anti‑inflammatory, and membrane‑stabilizing properties of vitamin E have prompted extensive research into its role in chronic disease prevention and treatment. This review synthesizes current evidence on the clinical benefits of vitamin E, delineates the mechanisms underlying these effects, and discusses documented adverse events associated with both deficiency and supraphysiologic supplementation.</p>
<hr>
<h3 id="2-clinical-benefits-of-vitamine">2. Clinical Benefits of Vitamin E</h3>
<table>
  <thead>
      <tr>
          <th>Domain</th>
          <th>Evidence Base</th>
          <th>Mechanistic Insights</th>
          <th>Practical Implications</th>
      </tr>
  </thead>
  <tbody>
      <tr>
          <td><strong>Cardiovascular Health</strong></td>
          <td>Randomized controlled trials (RCTs) in patients with atherosclerosis and post‑myocardial infarction cohorts show modest reductions in LDL oxidation; however, large meta‑analyses reveal no significant decrease in major cardiovascular events.</td>
          <td>α‑Tocopherol scavenges peroxyl radicals in low‑density lipoprotein particles, preventing lipid peroxidation that contributes to plaque formation.</td>
          <td>Routine supplementation beyond dietary intake is not recommended for primary prevention of CVD; targeted therapy may be considered in patients with documented oxidative stress markers.</td>
      </tr>
      <tr>
          <td><strong>Neurodegenerative Disorders</strong></td>
          <td>Small RCTs in Alzheimer’s disease and Parkinson’s disease demonstrate slow cognitive decline when high‑dose vitamin E (≥400 IU/day) is combined with cholinesterase inhibitors, but evidence remains inconclusive.</td>
          <td>Antioxidant action protects neuronal membranes from oxidative damage; potential modulation of microglial activation.</td>
          <td>Use cautiously as adjunct therapy; monitor for interactions with anticoagulants and other neuroprotective agents.</td>
      </tr>
      <tr>
          <td><strong>Cancer Prevention</strong></td>
          <td>Prospective cohort studies suggest reduced incidence of prostate, colorectal, and breast cancers among individuals with higher plasma α‑tocopherol levels. Yet, large RCTs (e.g., SELECT) have not confirmed a protective effect and even indicated increased prostate cancer risk at high doses.</td>
          <td>Vitamin E may inhibit NF‑κB signaling, reduce DNA damage, and modulate apoptosis pathways; however, excessive antioxidant capacity can impair physiological ROS signaling necessary for immune surveillance.</td>
          <td>No general recommendation for chemoprevention; consider individual risk profiles and ongoing clinical trials.</td>
      </tr>
      <tr>
          <td><strong>Eye Health</strong></td>
          <td>Age‑related macular degeneration (AMD) studies show that combined vitamin E, C, lutein, and zeaxanthin therapy slows progression in advanced stages.</td>
          <td>Antioxidant protection of photoreceptor cells from photo‑oxidative stress; anti‑angiogenic effects via VEGF modulation.</td>
          <td>Vitamin E is part of the AREDS2 formulation; dosing at 400 IU/day is standard for AMD patients with intermediate or advanced disease.</td>
      </tr>
      <tr>
          <td><strong>Dermatological Benefits</strong></td>
          <td>Topical vitamin E formulations improve wound healing, reduce scar formation, and ameliorate radiation dermatitis in breast cancer survivors.</td>
          <td>Stabilizes cellular membranes, reduces inflammatory cytokine release, and promotes collagen synthesis.</td>
          <td>Apply 0.5–1% tocopherol creams; avoid high‑concentration systemic use for skin conditions due to absorption variability.</td>
      </tr>
      <tr>
          <td><strong>Immune Modulation</strong></td>
          <td>In vitro studies show vitamin E enhances NK cell activity and T‑cell proliferation; clinical trials in elderly populations demonstrate modest improvements in vaccine responses.</td>
          <td>Acts as a cofactor for lymphocyte signaling pathways, reduces oxidative stress within immune cells, and supports cytokine production.</td>
          <td>Supplementation (200–400 IU/day) may be beneficial for immunosenescence but requires further large‑scale validation.</td>
      </tr>
  </tbody>
</table>
<hr>
<h3 id="3-mechanisms-underlying-vitamine-activity">3. Mechanisms Underlying Vitamin E Activity</h3>
<ol>
<li>
<p><strong>Free Radical Scavenging</strong></p>
<ul>
<li>α‑Tocopherol donates a hydrogen atom to lipid peroxyl radicals, terminating chain reactions in phospholipid bilayers. The resulting tocopheroxyl radical is readily reduced back by vitamin C or glutathione.</li>
</ul>
</li>
<li>
<p><strong>Modulation of Gene Expression</strong></p>
<ul>
<li>Vitamin E interacts with nuclear receptors (e.g., PPARγ) and transcription factors (e.g., NF‑κB, AP‑1), influencing the expression of antioxidant enzymes such as superoxide dismutase and catalase.</li>
</ul>
</li>
<li>
<p><strong>Membrane Stabilization &amp; Signal Transduction</strong></p>
<ul>
<li>By integrating into lipid rafts, vitamin E maintains membrane fluidity and facilitates receptor-mediated signaling, including insulin and growth factor pathways.</li>
</ul>
</li>
<li>
<p><strong>Anti‑Inflammatory Effects</strong></p>
<ul>
<li>Suppresses the production of pro‑inflammatory eicosanoids (e.g., leukotriene B4) and cytokines (IL‑6, TNF‑α), partly through inhibition of cyclooxygenase activity.</li>
</ul>
</li>
<li>
<p><strong>Protection Against Genotoxicity</strong></p>
<ul>
<li>Reduces oxidative DNA lesions (8‑oxoG) and maintains genomic stability in rapidly dividing cells.</li>
</ul>
</li>
</ol>
<hr>
<h3 id="4-adverse-effects-associated-with-vitamine">4. Adverse Effects Associated with Vitamin E</h3>
<table>
  <thead>
      <tr>
          <th>Category</th>
          <th>Clinical Manifestations</th>
          <th>Dose/Duration</th>
          <th>Management</th>
      </tr>
  </thead>
  <tbody>
      <tr>
          <td><strong>Bleeding Disorders</strong></td>
          <td>Prolonged clotting times, increased risk of hemorrhage (especially intracranial) in patients on anticoagulants (warfarin, DOACs).</td>
          <td>≥400 IU/day; &gt;12 months</td>
          <td>Discontinue or reduce dose; monitor INR/PT‑TCT; avoid concomitant NSAIDs.</td>
      </tr>
      <tr>
          <td><strong>Gastrointestinal Disturbances</strong></td>
          <td>Nausea, diarrhea, abdominal cramps.</td>
          <td>High‑dose oral preparations (≥800 IU/day)</td>
          <td>Reduce dosage; consider enteric‑coated formulations.</td>
      </tr>
      <tr>
          <td><strong>Allergic Reactions</strong></td>
          <td>Rash, pruritus, anaphylaxis in rare cases of tocopherol allergy.</td>
          <td>Any dose</td>
          <td>Immediate cessation; antihistamines or epinephrine if severe.</td>
      </tr>
      <tr>
          <td><strong>Interference with Vitamin K Metabolism</strong></td>
          <td>Elevated vitamin K‑dependent clotting factors may alter hepatic clearance of vitamin E.</td>
          <td>Chronic high intake</td>
          <td>Monitor liver function and coagulation parameters.</td>
      </tr>
      <tr>
          <td><strong>Impact on Immune Function</strong></td>
          <td>Excessive antioxidant capacity can blunt ROS‑mediated microbial killing, potentially increasing infection risk.</td>
          <td>Long‑term high doses (≥1,200 IU/day)</td>
          <td>Balance with other micronutrients; monitor for recurrent infections.</td>
      </tr>
      <tr>
          <td><strong>Cancer Risk at Supraphysiologic Levels</strong></td>
          <td>SELECT trial: 400 IU/day of α‑tocopherol increased prostate cancer incidence by ~7%.</td>
          <td>400–800 IU/day over ≥4 years</td>
          <td>Reevaluate long‑term use in high‑risk populations; consider alternative antioxidants.</td>
      </tr>
  </tbody>
</table>
<hr>
<h3 id="5-deficiency-states-and-clinical-consequences">5. Deficiency States and Clinical Consequences</h3>
<ul>
<li><strong>Neuromuscular Disorders</strong>: Ataxia, peripheral neuropathy, and ophthalmoplegia due to impaired axonal transport and retinal dysfunction.</li>
<li><strong>Hemolytic Anemia</strong>: Increased erythrocyte membrane fragility from lipid peroxidation; often presents with jaundice and splenomegaly.</li>
<li><strong>Impaired Wound Healing</strong>: Reduced collagen cross‑linking and fibroblast proliferation.</li>
<li><strong>Immune Dysregulation</strong>: Decreased lymphocyte proliferation, increased susceptibility to infections.</li>
</ul>
<p>Deficiency is most common in patients with fat malabsorption syndromes (cystic fibrosis, Crohn’s disease), bariatric surgery recipients, or chronic liver disease. Screening involves plasma α‑tocopherol levels; therapeutic dosing ranges from 200–400 IU/day for symptomatic individuals.</p>
<hr>
<h3 id="6-clinical-recommendations">6. Clinical Recommendations</h3>
<ol>
<li>
<p><strong>Dietary Intake</strong></p>
<ul>
<li>Encourage consumption of nuts, seeds, vegetable oils, and green leafy vegetables to achieve ≥15 mg/day (≈20 IU).</li>
</ul>
</li>
<li>
<p><strong>Supplementation Strategy</strong></p>
<ul>
<li>Reserve high‑dose supplementation (&gt;200 IU/day) for specific indications (AMD AREDS2 protocol, certain neurodegenerative conditions) under specialist supervision.</li>
</ul>
</li>
<li>
<p><strong>Monitoring</strong></p>
<ul>
<li>Baseline and periodic assessment of plasma α‑tocopherol levels in patients on long‑term therapy or with risk factors for deficiency or toxicity.</li>
</ul>
</li>
<li>
<p><strong>Drug Interactions</strong></p>
<ul>
<li>Review concurrent anticoagulant, antiplatelet, and anti‑inflammatory medications; adjust vitamin E dosing accordingly.</li>
</ul>
</li>
<li>
<p><strong>Patient Education</strong></p>
<ul>
<li>Counsel regarding signs of bleeding, allergic reactions, and the importance of adherence to prescribed doses.</li>
</ul>
</li>
</ol>
<hr>
<h3 id="7-conclusion">7. Conclusion</h3>
<p>Vitamin E remains a cornerstone antioxidant with multifaceted physiological roles. While evidence supports its utility in specific ocular, dermatologic, and potentially neuroprotective contexts, routine high‑dose supplementation for broad disease prevention is not justified and may carry significant risks. A nuanced, evidence‑based approach—tailored to individual patient profiles and guided by current clinical trials—is essential for optimizing therapeutic outcomes while minimizing adverse events.</p>
<hr>
<ul class="pa0">
  
   <li class="list di">
     <a href="/tags/vitamin/" class="link f5 grow br-pill ba ph3 pv2 mb2 dib black sans-serif no-underline">Vitamin</a>
   </li>
  
</ul>
<div class="mt6 instapaper_ignoref">
      
      
      </div>
    </div>

    <aside class="w-30-l mt6-l">




  <div class="bg-light-gray pa3 nested-list-reset nested-copy-line-height nested-links">
    <p class="f5 b mb3">Related</p>
    <ul class="pa0 list">
	   
	     <li  class="mb2">
          <a href="/post/Vitamin_A.html">Vitamin_A</a>
        </li>
	    
	     <li  class="mb2">
          <a href="/post/Vitamin_B12.html">Vitamin_B12</a>
        </li>
	    
	     <li  class="mb2">
          <a href="/post/Vitamin_B2.html">Vitamin_B2</a>
        </li>
	    
	     <li  class="mb2">
          <a href="/post/Vitamin_B3.html">Vitamin_B3</a>
        </li>
	    
	     <li  class="mb2">
          <a href="/post/Vitamin_B5.html">Vitamin_B5</a>
        </li>
	    
	     <li  class="mb2">
          <a href="/post/Vitamin_B6.html">Vitamin_B6</a>
        </li>
	    
	     <li  class="mb2">
          <a href="/post/Vitamin_B7.html">Vitamin_B7</a>
        </li>
	    
	     <li  class="mb2">
          <a href="/post/Vitamin_B9.html">Vitamin_B9</a>
        </li>
	    
	     <li  class="mb2">
          <a href="/post/Vitamin_C.html">Vitamin_C</a>
        </li>
	    
	     <li  class="mb2">
          <a href="/post/Vitamin_D.html">Vitamin_D</a>
        </li>
	    
	     <li  class="mb2">
          <a href="/post/Vitamin_D3.html">Vitamin_D3</a>
        </li>
	    
	     <li  class="mb2">
          <a href="/post/Vitamin_K.html">Vitamin_K</a>
        </li>
	    
	     <li  class="mb2">
          <a href="/post/vitamin_b1.html">Vitamin_B1</a>
        </li>
	    
    </ul>
</div>

</aside>

  </article>

    </main>
    <footer class="bg-black bottom-0 w-100 pa3" role="contentinfo">
  <div class="flex justify-between">
  <a class="f4 fw4 hover-white white-70 dn dib-ns pv2 ph3 no-underline" href="http://localhost:1313/" >
    &copy;  Health for you life 2025 
  </a>
    <div><div class="ananke-socials"></div>
</div>
  </div>
</footer>

  </body>
</html>
